Enable Injections announced today that it received CE mark approval for its EnFuse syringe transfer system for drug delivery. enFuse, an on-body delivery system, provides subcutaneous abdominal bolus administration of drug or biologic products in accordance with the drug product requirements. The mechanical, wearable device can deliver large volumes of small molecule and biologic medications […]
Enable Injections
Enable Injections inks deal to develop Parkinson’s therapy for delivery with EnFuse
Enable Injections announced today that it partnered with Serina Therapeutics to develop therapeutics for the enFuse delivery system. The companies aim to develop and commercialize SER-252 (POZ-apomorphine) in combination with enFuse to treat Parkinson’s disease. This deal builds upon a recent agreement that allows Roche to obtain a worldwide, exclusive license to develop and commercialize […]
Enable Injections, Roche expand enFuse delivery partnership
Enable Injections announced today that it expanded its collaboration with Roche to utilize its enFuse delivery technology in development programs. The partnership allows Roche to develop and apply Enable Injections’ expertise and enFuse technology to specific development programs. Through the collaboration, Roche can obtain a worldwide, exclusive license to develop and commercialize combinations of enFuse […]
Enable Injections to expand manufacturing facility to support drug delivery device production
Enable Injections announced today that it plans to expand its manufacturing operations with a new, large-scale facility in Ohio. In addition to the expansion in Springdale, Ohio, the company plans to enhance its corporate headquarters in Evendale, Ohio. Both facilities, nearby one another, sit just outside of Cincinnati. Enable Injections plans for its new 90,000-square-foot […]
Enable Injections promotes COO from within
Wearable drug delivery technology maker Enable Injections announced today that it named David Kroekel as its new COO. Cincinnati-based Enable develops the enFuse platform, whichallows hands-free, hidden needle drug delivery of up to 25 mL. Its simple design enables flexibility for at-home self-administration or in-clinic use. The FDA cleared the system for the delivery of […]
Enable Injections adds finance veteran to its board
Enable Injections announced today that it appointed Vickie Capps to its board of directors as the head of the audit committee. Capps joins the wearable drug delivery system maker with plenty of experience in finance and executive leadership. She also brings extensive board experience, including currently serving on the board of orthopedic company NuVasive. Other […]
FDA approves wearable injector from Enable Injections
Enable Injections announced today that it received FDA approval for its enFuse injector for the delivery of Empaveli. Empaveli, commercialized by Apellis Pharmaceuticals, treats adults with paroxysmal nocturnal hemoglobinuria (PNH). The injector — in this case, called the Empaveli Injector — offers self-administration of the pharmaceutical. The compact, wearable device streamlines the self-administration experience with […]
The biggest medical device VC deals of 2022
Last year was definitely a slower year for medical device VC deals than the year before. Biofourmis was the only medical device developer in the 10 largest healthcare VC deals of 2022, according to a ranking provided to Medical Design & Outsourcing by Silicon Valley Bank (SVB). Because we love devices at Medical Design & Outsourcing, we asked SVB for a […]
Enable Injections to add hundreds of jobs in Ohio
Enable Injections announced today that it committed to increasing jobs and payroll in the Cincinnati, Ohio region. The company intends to add 257 jobs and nearly $20 million in payroll in Cincinnati by 2027. Ohio’s Tax Credit Authority Board approved the commitment today. It allows the company to benefit from Ohio’s Job Creation Tax Credit […]
8 drug delivery innovations you need to know
The drug delivery space has seen plenty of innovation over the years and there are no signs of that slowing down any time soon. Improvements upon established technologies like insulin delivery devices and inhalers have been presented by some, while others have unlocked new ways of delivering drugs through a variety of means. Among the […]
